SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status

Molecular and Cellular Neuroscience

Volumn 35, Issue 4, 2007, Pages 525-534

  de Preux, Anne Sophie ^a   Goosen, Katinka ^b   Zhang, Weixian ^c   Sima, Anders A F ^c   Shimano, Hitoshi ^d   Ouwens, D Margriet ^e   Diamant, Michaela ^f   Hillebrands, Jan Luuk ^g   Rozing, Jan ^g   Lemke, Greg ^h   Beckmann, Jacques S ^a,i   Smit, August B ^b   Verheijen, Mark H G ^b   Chrast, Roman ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Diabetic peripheral neuropathy; Lipid metabolism; Schwann cell

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIET RESTRICTION; EXPERIMENTAL MODEL; GENE EXPRESSION; HORMONAL REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; LIPID METABOLISM; LIPID STORAGE; MOUSE; MYELINATION; NEUROCHEMISTRY; NONHUMAN; NUTRITIONAL STATUS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REFEEDING; RODENT; SCHWANN CELL;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; FASTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INSULIN; MICE; NUTRITIONAL STATUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIPHERAL NERVES; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RATS; RATS, INBRED STRAINS; SCHWANN CELLS; SCIATIC NERVE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TISSUE DISTRIBUTION;

RODENTIA;

EID: 34547408795     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.04.010     Document Type: Article

References (63)

1. Amemiya-Kudo M., Shimano H., Hasty A.H., Yahagi N., Yoshikawa T., Matsuzaka T., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Osuga J., Harada K., Gotoda T., Sato R., Kimura S., Ishibashi S., and Yamada N. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res. 43 (2002) 1220-1235
2. Becard D., Hainault I., Azzout-Marniche D., Bertry-Coussot L., Ferre P., and Foufelle F. Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50 (2001) 2425-2430
3. Brockes J.P., Fields K.L., and Raff M.C. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165 (1979) 105-118
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
5. Chrast R., Verheijen M.H., and Lemke G. Complement factors in adult peripheral nerve: a potential role in energy metabolism. Neurochem. Int. 45 (2004) 353-359
6. Clayton P.T. Clinical consequences of defects in peroxisomal beta-oxidation. Biochem. Soc. Trans. 29 (2001) 298-305
7. Coste T.C., Gerbi A., Vague P., Pieroni G., and Raccah D. Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy. Diabetes 52 (2003) 2578-2585
8. de Waegh S.M., Lee V.M.Y., and Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal-transport by myelinating Schwann-cells. Cell 68 (1992) 451-463
9. Dyck P.J., and Thomas P.K. Diabetic Neuropathy. 2nd ed. (1999), W.B. Saunders Company, Philadelphia
10. Frei R., Motzing S., Kinkelin I., Schachner M., Koltzenburg M., and Martini R. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 19 (1999) 6058-6067
11. Giannini C., and Dyck P.J. Axoglial dysjunction: a critical appraisal of definition, techniques, and previous results. Microsc. Res. Tech. 34 (1996) 436-444
12. Giese K.P., Martini R., Lemke G., Soriano P., and Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71 (1992) 565-576
13. Gosmain Y., Dif N., Berbe V., Loizon E., Rieusset J., Vidal H., and Lefai E. Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues. J. Lipid Res. 46 (2005) 697-705
14. Guillet-Deniau I., Mieulet V., Le Lay S., Achouri Y., Carre D., Girard J., Foufelle F., and Ferre P. Sterol regulatory element binding protein-1c expression and action in rat muscles - insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51 (2002) 1722-1728
15. Hanemann C.O., and Gabreels-Festen A.A.W.M. Secondary axon atrophy and neurological dysfunction in demyelinating neuropathies. Curr. Opin. Neurol. 15 (2002) 611-615
16. Hasty A.H., Shimano H., Yahagi N., Amemiya-Kudo M., Perrey S., Yoshikawa T., Osuga J., Okazaki H., Tamura Y., Iizuka Y., Shionoiri F., Ohashi K., Harada K., Gotoda T., Nagai R., Ishibashi S., and Yamada N. Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level. J. Biol. Chem. 275 (2000) 31069-31077
17. Horrobin D.F. The roles of essential fatty-acids in the development of diabetic neuropathy and other complications of diabetes-mellitus. Prostaglandins Leukot. Essent. Fat. Acids 31 (1988) 181-197
18. Horrobin D.F. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 46 (1997) S90-S93
19. Horton J.D., Bashmakov Y., Shimomura I., and Shimano H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5987-5992
20. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
21. Jamal G.A., and Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet. Med. 7 (1990) 319-323
22. Jump D.B. Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41 (2004) 41-78
23. Jurevics H.A., and Morell P. Sources of cholesterol for kidney and nerve during development. J. Lipid Res. 35 (1994) 112-120
24. Keen H., Payan J., Allawi J., Walker J., Jamal G.A., Weir A.I., Henderson L.M., Bissessar E.A., Watkins P.J., Sampson M., Gale E.A.M., Scarpello J., Boddie H.G., Hardy K.J., Thomas P.K., Misra P., and Halonen J.P. Treatment of diabetic neuropathy with gamma-linolenic acid. Diabetes Care 16 (1993) 8-15
25. Krarup C. An update on electrophysiological studies in neuropathy. Curr. Opin. Neurol. 16 (2003) 603-612
26. Le Lay S., Lefrere I., Trautwein C., Dugail I., and Krief S. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes - identification of CCAAT/enhancer-binding protein beta as an SREBP-1c target. J. Biol. Chem. 277 (2002) 35625-35634
27. Leblanc A.C., and Poduslo J.F. Regulation of apolipoprotein-E gene-expression after injury of the rat sciatic-nerve. J. Neurosci. Res. 25 (1990) 162-171
28. Leblanc S.E., Srinivasan R., Ferri C., Mager G.M., Gillian-Daniel A.L., Wrabetz L., and Svaren J. Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox-20 during peripheral nerve myelination. J. Neurochem. 93 (2005) 737-748
29. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., and Brown M.S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528
30. Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I., Sharma A.K., Boulton A.J.M., King R.H.M., Thomas P.K., and Ward J.D. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48 (2005) 578-585
31. Martini R. The effect of myelinating Schwann cells on axone. Muscle Nerve 24 (2001) 456-466
32. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Tomita S., Sekiya M., Hasty A., Nakagawa Y., Sone H., Toyoshima H., Ishibashi S., Osuga J., and Yamada N. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53 (2004) 560-569
33. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Yoshikawa T., Hasty A.H., Tamura Y., Osuga J., Okazaki H., Iizuka Y., Takahashi A., Sone H., Gotoda T., Ishibashi S., and Yamada N. Dual regulation of mouse Delta(5) - and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J. Lipid Res. 43 (2002) 107-114
34. Morell P., and Jurevics H. Origin of cholesterol in myelin. Neurochem. Res. 21 (1996) 463-470
35. Nakamura M.T., and Nara T.Y. Gene regulation of mammalian desaturases. Biochem. Soc. Trans. 30 (2002) 1076-1079
36. Okamoto K., Kakuma T., Fukuchi S., Masaki T., Sakata T., and Yoshimatsu H. Sterol regulatory element binding protein (SREBP)-1 expression in brain is affected by age but not by hormones or metabolic changes. Brain Res. 1081 (2006) 19-27
37. Ruiz-Gutierrez V., Stiefel P., Villar J., Garciadonas M.A., Acosta D., and Carneado J. Cell-membrane fatty-acid composition in type-1 (insulin-dependent) diabetic-patients - relationship with sodium-transport abnormalities and metabolic control. Diabetologia 36 (1993) 850-856
38. Salles J., Sargueil F., Knoll-Gellida A., Witters L.A., Cassagne C., and Garbay B. Acetyl-CoA carboxylase and SREBP expression during peripheral nervous system myelination. Biochim. Biophys. Acta 1631 (2003) 229-238
39. Sato R., Inoue J., Kawabe Y., Kodama T., Takano T., and Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271 (1996) 26461-26464
40. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99 (1997) 846-854
41. Shimomura I., Shimano H., Horton J.D., Goldstein J.L., and Brown M.S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99 (1997) 838-845
42. Sima A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci. 60 (2003) 2445-2464
43. Sima A.A.F. Diabetic polyneuropathy. J. Neuropathol. Exp. Neurol. 56 (1997) 458-458
44. Sima A.A.F., and Brismar T. Reversible diabetic nerve dysfunction - structural correlates to electrophysiological abnormalities. Ann. Neurol. 18 (1985) 21-29
45. Sima A.A.F., and Li Z.G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54 (2005) 1497-1505
46. Sima A.A., Nathaniel V., Bril V., McEwen T.A., and Greene D.A. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J. Clin. Invest. 81 (1988) 349-364
47. Sima A.A.F., Zhang W.X., Tze W.J., Tai J., and Nathaniel V. Diabetic neuropathy in Stz-induced diabetic rat and effect of allogeneic islet cell transplantation - morphometric analysis. Diabetes 37 (1988) 1129-1136
48. Sima A.A.F., Lattimer S.A., Yagihashi S., and Greene D.A. Axo-Glial dysjunction - a novel structural lesion that accounts for poorly reversible slowing of nerve-conduction in the spontaneously diabetic bio-breeding rat. J. Clin. Invest. 77 (1986) 474-484
49. Sima A.A.F., Zhang W., Sugimoto K., Henry D., Li Z., Wahren J., and Grunberger G. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 44 (2001) 889-897
50. Sima A.A.F., Zhang W., Xu G., Sugimoto K., Guberski D., and Yorek M.A. A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats. Diabetologia 43 (2000) 786-793
51. Sima A.A.F., Zhang W.X., Li Z.G., Murakawa Y., and Pierson C.R. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. Diabetes 53 (2004) 1556-1563
52. Sugimoto K., Murakawa Y., and Sima A.A. Diabetic neuropathy - a continuing enigma. Diabetes Metab. Res. Rev. 16 (2000) 408-433
53. Sun L., Halaihel N., Zhang W.P., Rogers T., and Levi M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J. Biol. Chem. 277 (2002) 18919-18927
54. Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., Nuber A., Pozza G., and Ward J.D. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39 (1996) 1377-1384
55. Thomas P.K., Beamish N.G., Small J.R., King R.H.M., Tesfaye S., Ward J.D., Tsigos C., Young R.J., and Boulton A.J.M. Paranodal structure in diabetic sensory polyneuropathy. Acta Neuropathol. 92 (1996) 614-620
56. Valls-Canals J., Povedano M., Montero J., and Pradas J. Diabetic polyneuropathy. Axonal or demyelinating?. Electromyogr. Clin. Neurophysiol. 42 (2002) 3-6
57. Verheijen M.H., Chrast R., Burrola P., and Lemke G. Local regulation of fat metabolism in peripheral nerves. Genes Dev. 17 (2003) 2450-2464
58. Vincent A.M., and Feldman E.L. New insights into the mechanisms of diabetic neuropathy. Rev. Endocr. Metab. Disord. 5 (2004) 227-236
59. Vinik A.I., and Mehrabyan A. Diabetic neuropathies. Med. Clin. North Am. 88 (2004) 947-999
60. Visser J., Klatter F., Vis L., Groen H., Strubbe J., and Rozing J. Long-term prophylactic insulin treatment can prevent spontaneous diabetes and thyroiditis development in the diabetes-prone bio-breeding rat, while short-term treatment is ineffective. Eur. J. Endocrinol. 149 (2003) 223-229
61. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., and Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12559-12563
62. Webster H.D. The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J. Cell Biol. 48 (1971) 348-367
63. Yao J.K., and Bourre J.M. Metabolic alterations of endoneurial lipids in developing trembler nerve. Brain Res. 325 (1985) 21-27